Posted on 8/10/20
Is Now the Right Time to Buy Novavax Stock?
One of the best-performing biotech stocks so far this year is Novavax (NASDAQ:NVAX). The company wasn't particularly well-known going into 2020, but its stock price has . . .
Posted on 8/4/20
Is BioCryst Pharmaceuticals Stock a Buy?
There are plenty of companies now developing treatments against the coronavirus to try to contain the pandemic. Small-cap biotech BioCryst Pharmaceuticals (NASDAQ:BCRX) is among them, and . . .
Posted on 6/1/20
Is Teva Pharmaceuticals Stock a Buy?
Teva Pharmaceutical Industries (NYSE:TEVA) is a well known generic drugmaker that's attracted the attention of a number of well-known investors in the past. Most notably, Warren . . .
Posted on 4/30/20
Is Emergent BioSolutions the Next Hot Coronavirus Stock?
When it comes to hot coronavirus stocks, investors have likely heard a lot about the many potential vaccines and other treatments currently being developed. However, there . . .
Posted on 4/23/20
Will Johnson & Johnson's Coronavirus Vaccine Dominate the Market?
Whether from niche vaccine developers or well-established pharmaceutical giants, over 70 potential coronavirus vaccines are currently undergoing development. Johnson & Johnson (NYSE:JNJ) was one of the . . .
Posted on 4/23/20
Is Deciphera Pharmaceuticals a Buy?
There are plenty of intriguing biotech stocks on the market right now, and many of them are trading at a steep discount due to the coronavirus . . .
Posted on 4/13/20
5 Biotech Stocks Winning the Coronavirus Race
There are quite a few companies that have found ways to grow their business during the ongoing COVID-19 pandemic. This is especially true for a number . . .
Posted on 4/13/20
Will Novavax Make Investors a Fortune?
Small-cap vaccine manufacturers have been some of the most volatile stocks on the market. As demand for a COVID-19 vaccine continues to grow, many companies working . . .
Posted on 4/13/20
5 Biotech Stocks Winning the Coronavirus Race
There are quite a few companies that have found ways to grow their business during the ongoing COVID-19 pandemic. This is especially true for a number . . .
Posted on 4/13/20
Is Alexion Pharmaceuticals a Buy?
There are plenty of promising biotech stocks for investors to sift through right now. One of these companies is Alexion Pharmaceuticals (NASDAQ:ALXN), a developer of treatments . . .
Posted on 4/13/20
5 Biotech Stocks Winning the Coronavirus Race
There are quite a few companies that have found ways to grow their business during the ongoing COVID-19 pandemic. This is especially true for a number . . .
Posted on 3/24/20
New York to Start Clinical Trials of Anti-Malaria Drugs for COVID-19
As the number of COVID-19 cases continues to rise across the U.S., many state authorities are trying anything they can to address the health crisis.On Tuesday, . . .
Posted on 3/20/20
Will Inovio Pharmaceuticals Make a Fortune Off Its Coronavirus Vaccine?
Inovio Pharmaceuticals (NASDAQ:INO) is easily one of the most volatile stocks on the market, thanks in no small part to the company's COVID-19 vaccine, INO-4800. With . . .
Posted on 3/19/20
Trump Signs Coronavirus Relief Bill Into Law
After hammering out the details regarding the coronavirus relief package proposed by the Trump administration, the Senate approved the bill on Wednesday, with President Trump signing . . .
Posted on 3/16/20
Pfizer Tells Entire Salesforce to Work Remotely Due To Coronavirus Pandemic
With the global coronavirus outbreak showing no sign of stopping, many companies around the world are asking employees who can work remotely to do so. Pfizer . . .
Posted on 3/13/20
Inovio Pharmaceuticals Announces Q4 Results, Stock Down 28%
Inovio Pharmaceuticals (NASDAQ:INO) has been one of the most volatile biotech stocks on the market as the company works on developing a potential COVID-19 coronavirus vaccine. . . .
Posted on 3/12/20
FDA Approves Bristol Myers Squibb's Liver Cancer Drug Combo
Bristol Myers Squibb (NYSE:BMY) announced on Wednesday that its liver cancer drug combo had officially received approval from the U.S. Food and Drug Administration. The Opdivo . . .
Posted on 3/11/20
Johnson & Johnson's CAR-T Partner Legend Biotech Plans IPO
Johnson & Johnson (NYSE:JNJ) partner Legend Biotech is planning for a U.S. initial public offering. The company, which is owned by the Hong Kong-listed GenScript Biotech, . . .
Posted on 3/10/20
Private-Equity Giant Blackstone Buys Stake in Healthcare Software Company HealthEdge
One of the largest private equity and alternative investment firms in the world just bought a majority stake of a promising healthcare software company. News broke . . .
Posted on 3/3/20
Novartis Subsidiary Agrees to Pay $195 Million Over Price-Fixing Charges
Novartis (NYSE:NVS) subsidiary Sandoz has plead guilty in its ongoing price-fixing case. The U.S. Justice Department, which has been investigating price-fixing schemes within the generic-drug industry, . . .
Posted on 2/28/20
Sangamo Therapeutics and Biogen Announce Gene-Therapy Deal, Stock up 39%
Sangamo Therapeutics (NASDAQ:SGMO) announced after the bell on Thursday that it signed a partnership with Biogen (NASDAQ:BIIB) to develop a number of gene-editing treatments. The scope . . .
Posted on 2/21/20
Merck's Chief Digital Officer Leaves to Join Marriott
One of Merck's (NYSE:MRK) top executives has left the company and the big pharma sector, in general, to work elsewhere. Jim Scholefield, Merck's chief digital officer, . . .
Posted on 2/20/20
Teva Pharmaceutical's Tourette Syndrome Drug Fails to Meet Endpoints
Teva Pharmaceutical Industries (NYSE:TEVA) announced Wednesday that two late-stage clinical trials evaluating deutetrabenazine (also known as Austedo) for use in patients with Tourette syndrome failed to . . .
Posted on 2/19/20
bluebird bio Beats Its Q4 Revenue Target but Misses on EPS
bluebird bio (NASDAQ:BLUE) announced its fourth-quarter and full-year financial results on Tuesday afternoon. The clinical-stage biotech's stock price fell a bit in after-hours trading as investors . . .
Posted on 2/18/20
Merck's Ebola Vaccine Approved for Use in Four African Countries
Merck (NYSE:MRK) announced on Friday that four African countries had approved the use of the company's Ebola vaccine, Ervebo. The Democratic Republic of the Congo (DRC), . . .
Posted on 2/14/20
Zoetis Reports Q4 Financial Results, Slightly Beats Revenue Estimates
Zoetis (NYSE:ZTS), the animal-health company, reported fiscal fourth-quarter and 2019 full-year financial results Thursday morning. Revenue slightly beat analyst expectations.Quarterly revenue came in at $1.7 billion, . . .
Posted on 2/12/20
Johnson & Johnson Announces Partnership With U.S. government to Accelerate Coronavirus Vaccine Development
Johnson & Johnson (NYSE:JNJ) announced on Tuesday afternoon that subsidiary Janssen Pharmaceutical will be working together with the U.S. government to expedite the development of a . . .
Posted on 2/11/20
Johnson & Johnson Submits FDA Application for Multiple Myeloma Drug
Johnson & Johnson (NYSE:JNJ) subsidiary Janssen announced on Monday that it had filed a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration . . .
Posted on 2/7/20
Johnson & Johnson Hit With $750 Million Fine Over Baby Powder Legal Case
On Thursday afternoon, news broke that a New Jersey state jury had ordered Johnson & Johnson (NYSE:JNJ) to pay $750 million in punitive damages to four . . .
Posted on 2/6/20
Biogen Surges After Winning Crucial Multiple Sclerosis Drug Patent
Biogen (NASDAQ:BIIB) is up 18% today as news regarding a crucial patent ruling came out in the company's favor. A U.S. appeals panels denied a patient . . .
Posted on 2/3/20
Biotech Bankruptcies Hit Recent High in 2019
Biotech investors might have had an exciting year in 2019 with an impressive amount of new drug approvals. There were 14 notable bankruptcies last year as . . .
Posted on 2/3/20
Bristol-Myers Withdraws European Application for Lung Cancer Combo
Bristol-Myers Squibb (NYSE:BMY) announced on Friday afternoon that it has withdrawn its European application for the company's Opdivo/Yervoy lung cancer drug combo. The company had hoped . . .
Posted on 2/3/20
Johnson & Johnson Ordered to Pay $344 Million for Deceptively Marketing Pelvic Mesh Product
Johnson & Johnson (NYSE:JNJ) was hit with a $344 million fine by a California state court for deceptively marketing regarding its pelvic mesh products. This ruling . . .
Posted on 1/31/20
Vertex Pharmaceuticals Reports Q4 Financial Earnings, Beats Estimates
Vertex Pharmaceuticals (NASDAQ:VRTX) announced its fourth-quarter financial results on Thursday afternoon, which were above analyst expectations. For the three months ending on Dec. 31, Vertex reported . . .
Posted on 1/30/20
Novartis Reports Q4 2019 Financial Results, Zolgensma Sales Fall Short
Swiss pharmaceutical giant Novartis (NYSE:NVS) announced its fourth-quarter 2019 financial results this morning. The company reported net sales of $12.4 billion, which was up 8% in . . .
Posted on 1/29/20
Johnson & Johnson's Nasal Spray Rejected in England Over Cost-Effectiveness
One of Britain's top healthcare agencies, the National Institute for Health and Care Excellence (NICE), announced on Tuesday that the group had decided to reject Johnson . . .
Posted on 1/24/20
Should Investors Be Worried About Merck's Keytruda?
Merck's (NYSE:MRK) cancer immunology drug, Keytruda, is already one of the best-selling drugs in the world and is well on track to becoming the No. 1 . . .
Posted on 1/22/20
Merck's Keytruda Could Face Direct Competition from New Chinese Drug
Chinese drug developer BeiGene (NASDAQ:BGNE) announced on Monday strong clinical results for its cancer immunotherapy, tislelizumab. A Phase 3 trial tested the drug alongside two other . . .
Posted on 1/16/20
Johnson & Johnson Seeks Expanded Use in Europe for Depression Nasal Spray
Johnson & Johnson's (NYSE:JNJ) subsidiary Janssen announced that it's seeking to expand the use of its depression nasal spray, Spravato, as a short-term treatment to be . . .
Posted on 1/16/20
Johnson & Johnson Seeks Expanded Use in Europe for Depression Nasal Spray
Johnson & Johnson's (NYSE:JNJ) subsidiary Janssen announced that it's seeking to expand the use of its depression nasal spray, Spravato, as a short-term treatment to be . . .
Posted on 1/3/20
Better Buy: Abbott Laboratories vs. Pfizer
Investors looking for large-cap, dividend-paying healthcare stocks have plenty of options. Whether it's large-scale drug manufacturers or medical technology providers, there's enough choice to suit whatever . . .
Posted on 1/3/20
Better Buy: Abbott Laboratories vs. Pfizer
Investors looking for large-cap, dividend-paying healthcare stocks have plenty of options. Whether it's large-scale drug manufacturers or medical technology providers, there's enough choice to suit whatever . . .
Posted on 12/19/19
How Big of a Deal Is Axsome Therapeutics' New Depression Drug?
Major single-day swings are a common occurrence in the biotech sector, as strong late-stage clinical results can send a stock surging. That's exactly what happened on . . .
Posted on 12/13/19
Should Investors Be Worried About Biogen's Alzheimer's Drug?
On Dec. 5, Biogen (NASDAQ:BIIB) announced its initial phase 3 trial results for its late-stage Alzheimer's drug candidate, aducanumab. While the results weren't entirely negative, investors . . .
Posted on 11/1/19
What Should Investors Think of Biogen's Alzheimer's Drug Candidate?
Investors and analysts alike received some surprising news last week when Biogen (NASDAQ:BIIB) announced that its Alzheimer's treatment candidate, aducanumab, was not the complete write off . . .
Posted on 10/29/19
Vertex Pharmaceuticals Gains FDA Approval for Cystic Fibrosis Drug
Vertex Pharmaceuticals (NASDAQ:VRTX) made news last week when its long-anticipated cystic fibrosis treatment, Trikafta, received approval from the U.S. Food and Drug Administration (FDA). While this . . .
Posted on 10/15/19
Johnson & Johnson Settles Ohio Opioid Cases for $20.4 Million to Avoid Federal Trial
Johnson & Johnson (NYSE:JNJ) made news in late August when a state judge in Oklahoma found the pharmaceutical giant guilty of deceptively marketing its opioid medications . . .
Posted on 10/15/19
Johnson & Johnson Settles Ohio Opioid Cases for $20.4 Million to Avoid Federal Trial
Johnson & Johnson (NYSE:JNJ) made news in late August when a state judge in Oklahoma found the pharmaceutical giant guilty of deceptively marketing its opioid medications . . .
Posted on 10/9/19
Should Investors Buy or Sell ConocoPhillips Right Now?
Oil prices have remained volatile since the initial attack on Saudi Arabia's oil facilities. Taking these geopolitical risks into consideration, analysts and shareholders alike have begun . . .
Posted on 9/30/19
Is GlaxoSmithKline a Buy?
Over the past several years, British pharmaceutical giant GlaxoSmithKline (NYSE:GSK) has been struggling to compete against some of its peers in the big pharma space. Despite . . .
Charlotte Raleigh
